A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.

Technology from the laboratories of IOCB Prague has been given an extraordinary opportunity to succeed in the rapidly developing segment of gene therapy.

Pavel Hobza from the IOCB Prague and his team discovered improper hydrogen bond twenty years ago. Current discovery has the potential to simplify the previously adopted definition of the hydrogen bond.

A piece of software which enables researchers worldwide to speed up their work and helps them make scientific discoveries is expanding from science into commerce.

Researchers from IOCB Prague determined the first cryo-EM structures of a surface receptor of the human parasite T. brucei gambiense in complex with human complement factor C3 in different conformations.

Dr Petr Cígler and his collaborators are working on refining molecular systems for transporting ribonucleic acid (RNA) molecules into cells.

State-of-the-art laboratories have found their home at Harfa in Prague, where preclinical research will be conducted to bring promising molecules closer to the development of important medications.

Prof. Josef Michl, a globally esteemed Czech chemist, suddenly passed on Monday, 13 May, at the age of 85.

Scientists are combining zero-dimensional (quantum dots), one-dimensional (e.g. nanotubes), and two-dimensional (e.g. graphene) materials in the lab to give them new and unusual properties.

IOCB Prague has founded a new branch in Boston, USA, the very heart of global biomedical research.